MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 1, Issue 6, Pages e26-e26
Publisher
Springer Nature
Online
2011-06-24
DOI
10.1038/bcj.2011.24
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
- (2010) L. Sanchez-Martin et al. BLOOD
- Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists
- (2010) A. Mandawat et al. BLOOD
- Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations
- (2010) D. T. Starczynowski et al. BLOOD
- miR-146a Suppresses Invasion of Pancreatic Cancer Cells
- (2010) Y. Li et al. CANCER RESEARCH
- Current and emerging therapies for acute myeloid leukemia
- (2010) Tadeusz Robak et al. CLINICAL THERAPEUTICS
- miR-146a Is Differentially Expressed by Myeloid Dendritic Cell Subsets and Desensitizes Cells to TLR2-Dependent Activation
- (2010) J. Jurkin et al. JOURNAL OF IMMUNOLOGY
- Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis
- (2009) Douglas R. Hurst et al. CANCER RESEARCH
- Chemokines in hematopoiesis
- (2009) Hal E Broxmeyer CURRENT OPINION IN HEMATOLOGY
- Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100
- (2009) Halvard Bonig et al. EXPERIMENTAL HEMATOLOGY
- miR-146a Is Critical for Endotoxin-induced Tolerance
- (2009) Md A. Nahid et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vitamin D3-driven signals for myeloid cell differentiation—Implications for differentiation therapy
- (2009) Philip J. Hughes et al. LEUKEMIA RESEARCH
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
- (2009) Daniel T Starczynowski et al. NATURE MEDICINE
- PLZF-mediated control on c-kit expression in CD34+ cells and early erythropoiesis
- (2009) I Spinello et al. ONCOGENE
- CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure
- (2008) M. Fiegl et al. BLOOD
- MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
- (2008) R. Garzon et al. BLOOD
- Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
- (2008) Z. Zeng et al. BLOOD
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
- (2008) B. Nervi et al. BLOOD
- The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation
- (2008) S Tavor et al. LEUKEMIA
- A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis
- (2008) Catherine Labbaye et al. NATURE CELL BIOLOGY
- Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
- (2008) Z. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now